- Home
- NUTR vs INCR Comparison
NUTR vs INCR Comparison
Compare NUTR & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTR
- INCR
- Stock Information
- Founded
- NUTR 2013
- INCR 1994
- Country
- NUTR Indonesia
- INCR Israel
- Employees
- NUTR N/A
- INCR N/A
- Industry
- NUTR
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- NUTR
- INCR Health Care
- Exchange
- NUTR Nasdaq
- INCR Nasdaq
- Market Cap
- NUTR 94.1M
- INCR 83.5M
- IPO Year
- NUTR 2025
- INCR N/A
- Fundamental
- Price
- NUTR $9.30
- INCR $1.62
- Analyst Decision
- NUTR
- INCR
- Analyst Count
- NUTR 0
- INCR 0
- Target Price
- NUTR N/A
- INCR N/A
- AVG Volume (30 Days)
- NUTR 2.7M
- INCR 133.3K
- Earning Date
- NUTR 11-02-2025
- INCR 08-28-2025
- Dividend Yield
- NUTR N/A
- INCR N/A
- EPS Growth
- NUTR N/A
- INCR N/A
- EPS
- NUTR 0.00
- INCR N/A
- Revenue
- NUTR $1,743,679.00
- INCR $65,575,323.00
- Revenue This Year
- NUTR N/A
- INCR $69.54
- Revenue Next Year
- NUTR N/A
- INCR $41.75
- P/E Ratio
- NUTR $3,995.74
- INCR N/A
- Revenue Growth
- NUTR N/A
- INCR N/A
- 52 Week Low
- NUTR $3.40
- INCR $1.17
- 52 Week High
- NUTR $9.50
- INCR $1.89
- Technical
- Relative Strength Index (RSI)
- NUTR N/A
- INCR 57.02
- Support Level
- NUTR N/A
- INCR $1.59
- Resistance Level
- NUTR N/A
- INCR $1.67
- Average True Range (ATR)
- NUTR 0.00
- INCR 0.07
- MACD
- NUTR 0.00
- INCR 0.02
- Stochastic Oscillator
- NUTR 0.00
- INCR 81.48
About NUTR Nusatrip Incorporated Common Stock
NusaTrip Inc operates as an Online Travel Agent offering Hotel & Flight Tickets, Domestic and International. The Company currently operates in a single reportable operating segment with five different services: Ticketing, Online advertisement, Hotel reservation, Hotel technology platform software, and Ancillary. The group earns revenue through commissions, service fees, and advertising partnerships.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.